These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 26089520)

  • 1. VACCINES. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells.
    Stary G; Olive A; Radovic-Moreno AF; Gondek D; Alvarez D; Basto PA; Perro M; Vrbanac VD; Tager AM; Shi J; Yethon JA; Farokhzad OC; Langer R; Starnbach MN; von Andrian UH
    Science; 2015 Jun; 348(6241):aaa8205. PubMed ID: 26089520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A live and inactivated Chlamydia trachomatis mouse pneumonitis strain induces the maturation of dendritic cells that are phenotypically and immunologically distinct.
    Rey-Ladino J; Koochesfahani KM; Zaharik ML; Shen C; Brunham RC
    Infect Immun; 2005 Mar; 73(3):1568-77. PubMed ID: 15731055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GM-CSF transgene-based adjuvant allows the establishment of protective mucosal immunity following vaccination with inactivated Chlamydia trachomatis.
    Lu H; Xing Z; Brunham RC
    J Immunol; 2002 Dec; 169(11):6324-31. PubMed ID: 12444139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective immunity against Chlamydia trachomatis can engage both CD4+ and CD8+ T cells and bridge the respiratory and genital mucosae.
    Nogueira CV; Zhang X; Giovannone N; Sennott EL; Starnbach MN
    J Immunol; 2015 Mar; 194(5):2319-29. PubMed ID: 25637024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines.
    He Q; Martinez-Sobrido L; Eko FO; Palese P; Garcia-Sastre A; Lyn D; Okenu D; Bandea C; Ananaba GA; Black CM; Igietseme JU
    Immunology; 2007 Sep; 122(1):28-37. PubMed ID: 17451464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Th1/Th17 T cell Tissue-Resident Immunity Increases Protection, But Is Not Required in a Vaccine Strategy Against Genital Infection With
    Nguyen NDNT; Guleed S; Olsen AW; Follmann F; Christensen JP; Dietrich J
    Front Immunol; 2021; 12():790463. PubMed ID: 34925371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes.
    Igietseme JU; Murdin A
    Infect Immun; 2000 Dec; 68(12):6798-806. PubMed ID: 11083798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive CD4+ T cells.
    Yu H; Jiang X; Shen C; Karunakaran KP; Jiang J; Rosin NL; Brunham RC
    Infect Immun; 2010 May; 78(5):2272-82. PubMed ID: 20231405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against genital tract Chlamydia trachomatis infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen.
    Hadad R; Marks E; Kalbina I; Schön K; Unemo M; Lycke N; Strid Å; Andersson S
    APMIS; 2016 Dec; 124(12):1078-1086. PubMed ID: 27859689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae.
    Su H; Messer R; Whitmire W; Fischer E; Portis JC; Caldwell HD
    J Exp Med; 1998 Sep; 188(5):809-18. PubMed ID: 9730883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput proteomic screening identifies Chlamydia trachomatis antigens that are capable of eliciting T cell and antibody responses that provide protection against vaginal challenge.
    Picard MD; Cohane KP; Gierahn TM; Higgins DE; Flechtner JB
    Vaccine; 2012 Jun; 30(29):4387-93. PubMed ID: 22682294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multi-subunit Chlamydia vaccine inducing neutralizing antibodies and strong IFN-γ⁺ CMI responses protects against a genital infection in minipigs.
    Bøje S; Olsen AW; Erneholm K; Agerholm JS; Jungersen G; Andersen P; Follmann F
    Immunol Cell Biol; 2016 Feb; 94(2):185-95. PubMed ID: 26268662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IMMUNOLOGY. A Chlamydia vaccine on the horizon.
    Brunham RC
    Science; 2015 Jun; 348(6241):1322-3. PubMed ID: 26089500
    [No Abstract]   [Full Text] [Related]  

  • 14. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.
    Kim KH; Lee YT; Hwang HS; Kwon YM; Kim MC; Ko EJ; Lee JS; Lee Y; Kang SM
    J Virol; 2015 Nov; 89(22):11692-705. PubMed ID: 26355098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcutaneous immunization with a novel lipid-based adjuvant protects against Chlamydia genital and respiratory infections.
    Hickey DK; Aldwell FE; Beagley KW
    Vaccine; 2009 Oct; 27(44):6217-25. PubMed ID: 19698810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type I IFN signalling is required for cationic adjuvant formulation (CAF)01-induced cellular immunity and mucosal priming.
    McEntee CP; Moran HBT; Muñoz-Wolf N; Liddicoat AM; Carroll EC; Erbo-Wern J; Coulter IS; Andersen P; Follmann F; Lavelle EC
    Vaccine; 2020 Jan; 38(3):635-643. PubMed ID: 31727505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Excess of the Proinflammatory Cytokines IFN-γ and IL-12 Impairs the Development of the Memory CD8+ T Cell Response to Chlamydia trachomatis.
    Zhang X; Starnbach MN
    J Immunol; 2015 Aug; 195(4):1665-75. PubMed ID: 26179901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatis.
    Coler RN; Bhatia A; Maisonneuve JF; Probst P; Barth B; Ovendale P; Fang H; Alderson M; Lobet Y; Cohen J; Mettens P; Reed SG
    FEMS Immunol Med Microbiol; 2009 Mar; 55(2):258-70. PubMed ID: 19281568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating memory CD8
    Behr FM; Beumer-Chuwonpad A; Kragten NAM; Wesselink TH; Stark R; van Gisbergen KPJM
    Eur J Immunol; 2021 Jan; 51(1):151-166. PubMed ID: 32762051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant polymorphic membrane protein D in combination with a novel, second-generation lipid adjuvant protects against intra-vaginal Chlamydia trachomatis infection in mice.
    Paes W; Brown N; Brzozowski AM; Coler R; Reed S; Carter D; Bland M; Kaye PM; Lacey CJN
    Vaccine; 2016 Jul; 34(35):4123-4131. PubMed ID: 27389169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.